NCT03585166

Brief Summary

This study was divided into laparoscopic hepatectomy (observation group) and laparoscopic hepatectomy (control group).Compared two groups of age, sex, body mass index (BMI), tumor diameter, number of tumors (single/multiple), pathologic characteristics, HBsAg (positive/negative), liver function, AFP, Child - Pugh, grading, nursing method and comparison of two groups of patients after surgery (surgical incision length, intraoperative blood, intraoperative blood transfusion and transfusion volume, operation time) the number of cases of and postoperative rehabilitation (death cases, for the first time the meal time, anus exhaust time, analgesic bed, first time, the abdominal cavity drainage tube time, length of hospital stay, postoperative days and liver function index.Follow-up: the survival rates of the two groups were compared in six months, one year, two years, three years and five years.In this study, the initial selection of the minimum sample size of 30 cases, plus 20% inefficiencies, the final initial selection of 36 cases, and the later expansion of the sample size of 100 cases.The research date starts on October 1, 2017.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 12, 2018

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

July 12, 2018

Status Verified

June 1, 2018

Enrollment Period

6.1 years

First QC Date

April 24, 2018

Last Update Submit

June 30, 2018

Conditions

Keywords

Liver Cancerlaparoscopic hepatectomyopen hepatectomy

Outcome Measures

Primary Outcomes (8)

  • The incidence of complications of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,The questionnaire survey

    The incidence of complications, in percent

    Patients with hepatocellular carcinoma who were hospitalized together on October 1, 2017 were studied at the time point before discharge.

  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit

    Survival rate, percent

    1 month after discharge

  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit

    Survival rate, percent

    3 month after discharge

  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit

    Survival rate, percent

    6 month after discharge

  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit

    Survival rate, percent

    1 year after discharge

  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit

    Death and recurrence

    2 year after discharge

  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit

    Death and recurrence

    3 year after discharge

  • The survival rate of primary liver cancer treated by laparoscopic hepatectomy and laparoscopic hepatectomy,Telephone pays a return visit

    Survival rate, percent

    5 year after discharge

Secondary Outcomes (6)

  • Comparison of oxygen uptake days between laparoscopic hepatectomy and laparoscopic hepatectomy for primary liver cancer, unit: day

    Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.

  • Comparison of ecg monitoring days between laparoscopic hepatectomy and laparoscopic hepatectomy for primary liver cancer Unit: day

    Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.

  • Comparison of the number of replacement drainage bags for primary hepatocellular carcinoma between laparoscopic hepatectomy and laparoscopic hepatectomy, unit: number

    Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.

  • Comparison of infusion days between laparoscopic hepatectomy and laparoscopic hepatectomy for primary liver cancer Unit: day

    Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.

  • Comparison of muscle injection times between laparoscopic hepatectomy and laparoscopic hepatectomy in primary liver cancer: times

    Patients with liver cancer who are hospitalized on 1 October 2017 will be included in the study date.The study time is 1 year.

  • +1 more secondary outcomes

Study Arms (2)

laparoscopic hepatectomy

laparoscopic hepatectomy for primary liver cancer

Procedure: lpaparoscopic hepatectomy

open hepatectomy

open hepatectomy for primary liver cancer

Procedure: open hepatectomy

Interventions

laparoscopic hepatectomy: laparoscopic hepatectomy for hepatocellular carcinoma.

laparoscopic hepatectomy

open hepatectomy: open hepatectomy for hepatocellular carcinoma

open hepatectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

adult, aged (18- N/A),male/femal,diagnosised with primary hepatoma, received surgical intervention(laparoscopic and open)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Union hospital

Wuhan, Hubei, 403322, China

RECRUITING

MeSH Terms

Conditions

Liver Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver Diseases

Study Officials

  • Li Zeng

    Department of Hepatobiliary,Union Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Charge nurse

Study Record Dates

First Submitted

April 24, 2018

First Posted

July 12, 2018

Study Start

October 1, 2017

Primary Completion

October 31, 2023

Study Completion

October 31, 2023

Last Updated

July 12, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations